Fundz

Abselion raised £6.6M in a Series A funding round led by M Ventures to drive the commercialisation and expand the capabilities of its Amperia system.

PRIVATEDec 09, 2024

Amount Raised

£6.6 Million

Round Type

Series A

CambridgeBiotechnology

Investors

M VenturesBioProcess 360 PartnersR42BgfUntitled Ventures

Description

Abselion, a Cambridge-based company that specializes in automated analytical instrumentation, raised £6.6M in Series A funding. This round was led by M Ventures with participation from BioProcess 360 Partners, Untitled Ventures, BGF, and R42. The company intends to use the funds for the commercialisation and expansion of its Amperia system.

Quick answer

Abselion raised £6.6 Million in a Series A round, dated December 9, 2024. Investors: M Ventures, BioProcess 360 Partners, R42, Bgf and Untitled Ventures. Abselion is based in Cambridge, England, United Kingdom.

How much did Abselion raise?
Abselion raised £6.6 Million in a Series A round on December 9, 2024.
Who invested in Abselion?
M Ventures, BioProcess 360 Partners, R42, Bgf and Untitled Ventures are named as investors in this round.
What does Abselion do?
Abselion is a company based in Cambridge, UK, specializing in automated analytical instrumentation that simplifies at-line protein quantification.
Where is Abselion based and how big is it?
Abselion is based in Cambridge, England, United Kingdom. Fundz records about 22 employees.
Who are the decision-makers at Abselion?
Fundz holds 2 contacts at Abselion. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Abselion that raised within 45 days of this round, from Fundz verified event records.

  • MyndTec raised $100K (Pre-Seed) on January 23, 2025.
  • MED-X raised $428K on January 23, 2025.
  • Sycai Medical raised $3.1M (Seed) on January 23, 2025.
  • SVASTEK raised $231K (Seed) on January 23, 2025.
  • Nuclein raised $750K (Seed) on January 23, 2025.
  • Resynergi raised $18M on January 23, 2025.

Who to call at Abselion, and when

A new round usually means Abselion is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Abselion raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Abselion, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Abselion. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Abselion

Location

Cambridge, England, United Kingdom

About

Abselion is a company based in Cambridge, UK, specializing in automated analytical instrumentation that simplifies at-line protein quantification. The company’s Amperia system uses redox-electrochemical-detection (RED) technology to streamline access to process insights in biopharmaceutical research and production. It allows scientists to quantify antibodies and proteins from crude samples quickly, enhancing efficiency and accuracy in life science research. Abselion aims to drive commercialization and expand the capabilities of its technology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Abselion raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Abselion's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Abselion raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.